Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics

Live imaging with uniform super-resolution in all spatial dimensions.

A modular system for precise and automated cell dispensing

How the benefits of laboratory automation can be combined with gentle cell handling.

Lonza

Scientific Solutions

RegSmart Life Science AB

New Horizons in Biologics & Bioprocessing: Copenhagen 2026

Are you ready for EMC 2024?

Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.

Aurevia

WuXi AppTec, UK Ltd

Medicon Valley Alliance

Mercodia AB

Galderma

Truly Labs AB

Accelerate your Research with AI-Powered Image Analysis

Comprehensive eBook from ZEISS.

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Thumbs down for lecanemab in the EU – “Very surprised”

The Azheimer's drug lecanemab has received a negative assessment from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), acc...

SGS Fimko Ltd.

Healthcare study: Alzheimer’s blood test shows high accuracy

A blood test for identifying Alzheimer’s has now been tested in the general healthcare setting. According to the researchers, the test was 90% accurate in making a diagnosis.

JMP Statistical Discovery

QPS Netherlands B.V

ProPharma

Medeon AB